中科信息(300678.SZ):暫無汽車智能駕駛領域相關業務
格隆匯4月3日丨中科信息(300678.SZ)在投資者互動平臺表示,公司暫無汽車智能駕駛領域相關業務。公司高速機器視覺與智能分析技術的應用面很廣,現主要用於大規模生產在線實時檢測場景,印鈔、菸草、電子玻璃、汽車玻璃、浮法玻璃、手機屏、鋰電池薄膜、半導體、藥品膠囊等行業都有應用。爲進一步提高檢測精度、速度和抗幹擾能力,滿足更復雜、多樣性環境下的識別需求,目前正在推進多模態工業檢測大模型的研發。同時,公司運用機器視覺與智能分析、自動駕駛、工程施工全自動化技術,與四川路橋集團合作研發的智能裝載機器人(一期)已通過驗收,開始試用,智能鋪路機器人正在進行測試。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.